Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2007 Results
Date:2/28/2008

Clinical Sales Growth of 211 Percent Highlights Company Transition to

Clinical Market

SUNNYVALE, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced financial results for the fourth quarter and full year ended December 31, 2007.

Key results for the full year 2007:

-- Total revenues of $129.5 million, a 48 percent increase from

$87.4 million for the full year of 2006

- Total product sales of $116.5 million, a 41 percent increase from

$82.4 million for the full year of 2006

* Clinical product sales of $61.0 million, a 211 percent

increase from $19.6 million for the full year of 2006

-- Cumulative total of 2,008 diagnostic modules of the GeneXpert(R) System

installed in U.S. accounts and 561 installed in Europe as of

December 31, 2007

-- Net loss, excluding stock compensation expense and the amortization of

acquired intangibles, of $9.3 million, or $0.17 per share, compared to

$18.6 million, or $0.36 per share, for the full year 2006

"The year 2007 was a break-out year for Cepheid as we realized significant market traction with the only fully integrated system for on-demand PCR-based DNA testing in the clinical market," said John Bishop, Cepheid's Chief Executive Officer. "Moving into 2008, our momentum continues with the expansion of worldwide market penetration of the GeneXpert System into the three key MRSA market segments: surveillance, diagnosis and pre-surgical testing. We also expect to see expansion into additional Healthcare-Associated Infection (HAI) markets including tests for Vancomycin-resistant Enterococci (VRE) and C. difficile. We will also focus on expanding our test menu to address additional high-margin clinical segments, including oncology."

Fourth Quarter and Full Year 2007 Results:

Total revenues of $40.4 m
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
2. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
3. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
4. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
7. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
8. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
9. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
10. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
11. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations ... events in the United States and ... Virginia Cox , JD, is returning to the firm,s ... Virginia Cox re-joins 3D after more than two years ... Affairs at the U.S. Food and Drug Administration (FDA). As ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, ... joining together with two institutes from the National ... more reliable tools for bringing safer, more effective ... is collaborating with the National Center for Advancing ... (NEI) to develop better and more clinically predictive ...
(Date:1/14/2014)... MD (PRWEB) January 14, 2014 ... to developing innovative information technology solutions for patients, ... health care stakeholders, announced today the signing of ... US Food and Drug Administration (FDA). This ... challenges related to patient safety, clinical outcomes, and ...
(Date:1/14/2014)... 14, 2014 During the 1600’s through ... known as “The Doctor’s Plague.” In this time period, ... their hands. This led, at times, to the death ... and hospital staff today don’t know that they may ... CBCD explains. , A study showed that severe fatigue ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... STAMFORD, Conn., Sept. 17 Cowen Healthcare ... established a Strategic Advisory Board to extend the Firm,s ... The Board will be comprised of industry veterans with ... is expected to supplement Cowen Royalty,s due diligence, opportunity ...
... ... its Board of Directors. , ... Alachua, FL (PRWEB) September 16, 2009 -- NovaMin Technology Inc. (NTI) announced ... is President and CEO of Columbia Biosciences Corporation which he founded in 2007 to ...
... , COLUMBIA, Md., Sept. 16 Martek Biosciences (Nasdaq: ... Pernock to its Board of Directors. , , ... in the commercialization of pharmaceutical products, having served from 1994 to ... of the world,s leading healthcare companies. In his most recent executive ...
Cached Biology Technology:Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 2Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 3Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 4NovaMin Technology Inc. Welcomes New Board Member 2Martek Announces Addition to Its Board of Directors 2
(Date:3/13/2014)... news release is available in German . ... (DFG, German Research Foundation) will award the Ursula M. ... improved the welfare of animals used in research, for ... euros will be awarded to Professor Thomas Korff, who ... for Physiology and Pathophysiology at the University of Heidelberg, ...
(Date:3/13/2014)... March 13, 2014 Only one third of ... for psychosis actually convert to a psychotic disorder ... assessment is based on the presence of sub-threshold ... do not predict future psychosis risk with sufficient ... medications such as antipsychotics that produce significant side ...
(Date:3/13/2014)... new heat-based technique for counting and measuring the ... expensive than light-based techniques and can be used ... techniques. The research was performed by faculty at ... Carolina at Chapel Hill and Marquette University. , ... but it,s developed into a technique that has ...
Breaking Biology News(10 mins):Outstanding research on improving animal welfare in science 2Outstanding research on improving animal welfare in science 3A brain signal for psychosis risk 2Heat-based technique offers new way to measure microscopic particles 2
... research published online in the FASEB Journal ... plays a key role in cell death induced by ... help prevent or lessen the severity of immune problems ... conditions initiate health problems that mimic the aging process ...
... dramatically increase the life span of mice with progeria ... muscular dystrophy) by reducing levels of a protein called ... Medical Biology (IMB) in collaboration with their partners at ... the United States and the Institute of Cellular and ...
... BOSTON Binkies, corks, soothers. Whatever you call ... can interfere with breastfeeding. New research, however, ... pacifiers in newborn nurseries may actually increase infants, consumption ... study to be presented Monday, April 30, at the ...
Cached Biology News:Scientists discover enzyme that could slow part of the aging process in astronauts -- and the elderly 2Scientists uncover exciting lead into premature aging and heart disease 2Researchers question pulling plug on pacifiers 2
... ReadySub-Cell GT cell and PowerPac basic power supply ... nucleic acids in agarose gels. The mini format ... and electrodes, and leveling bubble. The PowerPac basic ... of 10-300 V, 4-400 mA, and 75 W. ...
... and you reduce the chance of error. ... 8000. Developed using Beckman Coulters extensive experience ... electrophoresis technology, the CEQ 8000 is a ... automatically fills the capillary array with a ...
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
... The APO-BRDU Kit is a 2-color staining ... cellular DNA to detect apoptotic cells by ... and reagents required for measuring apoptosis in ... for assessing reagent performance; washing, reaction and ...
Biology Products: